Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa?

Article ID	Journal	Published Year	Pages	File Type
10966543	Vaccine	2013	8 Pages	PDF

Abstract

âº Risk behaviour over time in the first HIV efficacy trial in South Africa is reported. âº No evidence of sexual risk compensation is observed. âº Good uptake of medical circumcision among male participants.

Keywords

HIV vaccine trials South Africa Perception of risk

Related Topics

Life Sciences Immunology and Microbiology Immunology

Preview

Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa?

Authors

G.E. Gray, B. Metch, G. Churchyard, K. Mlisana, M. Nchabeleng, M. Allen, Z. Moodie, J. Kublin, L.-G. Bekker, on behalf of the HVTN 503 team on behalf of the HVTN 503 team,